You searched for metabolic diseases - Page 41 of 63

News and Trends 20 Mar 2020

Themis and Institut Pasteur Join Coronavirus Vaccine Hunt

The Austrian biotech Themis — specializing in vaccines for infectious and insect-borne diseases — has jumped on the coronavirus vaccine bandwagon along with the Institut Pasteur and other international partners….

March 20, 2020 - 3 minutesmins - By Jonathan Smith

In Depth 17 Oct 2017

Blockbuster Potential: How Biotech is Paving the Way to Clear Skin from Psoriasis

…it. Today you can be a severe psoriasis sufferer and live with almost clear skin.” However, Thormann adds, “I think that as in many other diseases, there are two main…

October 17, 2017 - 7 minutesmins - By Diana Kwon

In Depth 13 May 2024

New antidepressants: tackling treatment resistant depression

…diseases such as cardiovascular diseases, cancers, immune/inflammatory diseases, etc. In light of these intricate comorbidity pictures of depression, it is essential to note that while a diagnosis of depression can…

May 13, 2024 - 11 minutesmins - By Willow Shah-Neville

Expert Advice 14 Mar 2023

5 reasons why collaboration is important in research

…and speed up drug development, which is crucial when working towards developing successful treatments for a range of complex diseases. With regards to expertise, Linscott commented that the body of…

March 14, 2023 - 7 minutesmins - By Willow Shah-Neville

News and Trends 14 Dec 2022

Replay targets genetic brain disorders with new gene therapy company, Kaleibe

…whose research at the University of Oxford focuses on the molecular mechanisms underlying neurodegenerative diseases, and Howard J Federoff, former distinguished Professor of Neurology at University of California, Irvine, and…

December 14, 2022 - 4 minutesmins - By Jim Cornall

Best in Biotech 19 Sep 2023

Five biotech companies taking Los Angeles by storm

…urticaria. Capsida Biotherapeutics Gene therapy platform company Capsida Biotherapeutics is working on the development of a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening diseases…

September 19, 2023 - 6 minutesmins - By Willow Shah-Neville

News and Trends 25 Aug 2022

Evotec SE acquires highly-flexible drug manufacturing space for €1

…in depth – and with it the number of rare diseases that we can meaningfully distinguish and target with precision medicine. “Evotec DS reinforces our commitment to rare diseases by…

August 25, 2022 - 2 minutesmins - By Liza Laws

Interview 20 Mar 2018

Why It’s the Best Time to Be in Cell and Gene Therapy

…for diseases with short-term mortality, such as cancer. However, for more complex, chronic diseases such as diabetes, he expects “it will take a long time to get there.” With the…

March 20, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

genetic sequencing DNA Human Genome Project HGP

Opinion 14 Apr 2023

20 years ago today: how genetic sequencing is changing lives since the Human Genome Project

…and treatment in the fields of cancer, infectious diseases, rare and undiagnosed diseases, non-communicable diseases and pharmacogenomic diseases, all of which are important areas of research that can contribute to…

April 14, 2023 - 6 minutesmins - By External Contributor

boehringer ingelheim abbvie psoriasis interleukin23 bi655066 bi655066 Crohns asthma psoriatic arthritis

News and Trends 9 Mar 2016

Boehringer Ingelheim Gets €540M upfront for the next Potential Antibody Blockbuster

Boehringer Ingelheim (Germany) has entered a new collaboration with AbbVie (US) to develop two new candidates for immune diseases, including psoriasis and Crohn’s disease. Therapies for immune diseases continue to…

March 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

Navigating cell and gene therapy manufacturing with a long-term partnership

Cell and gene therapies have proven to be promising treatments for cancers and genetic diseases, but developers face key challenges before these treatments reach patients’ bedsides. A long-term partnership with…

January 17, 2023 - 7 minutesmins - By Alexander Burik

News and Trends 15 Nov 2022

BrainEver and 3P Biopharmaceuticals developing drug with hopes to cure ALS

…for the treatment of neurodegenerative diseases. 3P BioPharmaceuticals’ role will focus on the transfer of the production process as well as the cGMP manufacturing of the drug substance to be…

November 15, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Themis and Institut Pasteur Join Coronavirus Vaccine Hunt

Blockbuster Potential: How Biotech is Paving the Way to Clear Skin from Psoriasis

New antidepressants: tackling treatment resistant depression

5 reasons why collaboration is important in research

Replay targets genetic brain disorders with new gene therapy company, Kaleibe

Five biotech companies taking Los Angeles by storm

Evotec SE acquires highly-flexible drug manufacturing space for €1

Why It’s the Best Time to Be in Cell and Gene Therapy

20 years ago today: how genetic sequencing is changing lives since the Human Genome Project

Boehringer Ingelheim Gets €540M upfront for the next Potential Antibody Blockbuster

Navigating cell and gene therapy manufacturing with a long-term partnership

BrainEver and 3P Biopharmaceuticals developing drug with hopes to cure ALS

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!